Your browser doesn't support javascript.
loading
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.
Gürbüz, Mustafa; Akkus, Erman; Sakin, Abdullah; Urvay, Semiha; Demiray, Atike Gökçen; Sahin, Süleyman; Sakalar, Teoman; Erol, Cihan; Sendur, Mehmet Ali Nahit; Sahin, Ahmet Bilgehan; Çubukçu, Erdem; Güven, Deniz Can; Kiliçkap, Saadettin; Ergün, Yakup; Uncu, Dogan; Turhal, Nazim Serdar; Üskent, Necdet; Yesil Çinkir, Havva; Demir, Atakan; Acar, Ramazan; Karadurmus, Nuri; Türker, Sema; Altinbas, Mustafa; Karaoglan, Mert; Çay Senler, Filiz.
Afiliação
  • Gürbüz M; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Akkus E; Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Sakin A; Department of Medical Oncology, Van Yüzüncü Yil University Faculty of Medicine, Van, Turkey.
  • Urvay S; Department of Medical Oncology, Kayseri Acibadem Hospital, Kayseri, Turkey.
  • Demiray AG; Department of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
  • Sahin S; Department of Medical Oncology, University of Health Sciences, Van Training and Research Hospital, Van, Turkey.
  • Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey.
  • Erol C; Department of Medical Oncology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey.
  • Sendur MAN; Department of Medical Oncology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey.
  • Sahin AB; Department of Medical Oncology, Uludag University Faculty of Medicine, Bursa, Turkey.
  • Çubukçu E; Department of Medical Oncology, Uludag University Faculty of Medicine, Bursa, Turkey.
  • Güven DC; Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Kiliçkap S; Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Ergün Y; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Uncu D; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
  • Üskent N; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
  • Yesil Çinkir H; Department of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.
  • Demir A; Department of Medical Oncology, Maslak Acibadem Hospital, Istanbul, Turkey.
  • Acar R; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Karadurmus N; Department of Medical Oncology, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
  • Türker S; Department of Medical Oncology, Diskapi Yildirim Beyazid Education and Research Hospital, Ankara, Turkey.
  • Altinbas M; Department of Medical Oncology, Diskapi Yildirim Beyazid Education and Research Hospital, Ankara, Turkey.
  • Karaoglan M; Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Çay Senler F; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
Tumori ; 107(5): 416-423, 2021 Oct.
Article em En | MEDLINE | ID: mdl-33167790
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Hidrocarbonetos Aromáticos com Pontes / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Taxoides / Trastuzumab Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tumori Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Hidrocarbonetos Aromáticos com Pontes / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Taxoides / Trastuzumab Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tumori Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia